UK Orphan Drug Access Slammed; Shire Calls For Urgent 'Access Summit'

Orphan drugs "are falling through the cracks" of the UK’s market access process, Shire's country general manager tells the Pink Sheet and calls for urgent all-party remedial talks.

Access

More from Health Technology Assessment

More from Market Access